Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,052 | 84,008 | 68,849 | 79,724 | 56,336 |
| Marketable Securities | 4,584 | 23,579 | 54,247 | 34,158 | 73,082 |
| Receivables | 9,062 | 3,809 | 5,143 | 4,993 | 4,043 |
| TOTAL | $109,341 | $115,986 | $133,132 | $124,520 | $139,548 |
| Non-Current Assets | |||||
| PPE Net | 34,401 | 35,516 | 37,362 | 35,990 | 35,571 |
| Investments And Advances | 0 | 0 | 0 | 5,738 | 5,693 |
| Intangibles | 29,438 | 29,738 | 30,038 | 30,338 | 30,638 |
| Other Non-Current Assets | 214 | 727 | 1,240 | 2,303 | 2,385 |
| TOTAL | $64,053 | $65,981 | $68,640 | $74,369 | $74,287 |
| Total Assets | $173,394 | $181,967 | $201,772 | $198,889 | $213,835 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,078 | 2,752 | 4,378 | 4,270 | 4,406 |
| Accrued Expenses | 7,211 | 3,534 | 4,161 | 4,782 | 4,565 |
| TOTAL | $23,940 | $16,789 | $21,299 | $17,346 | $18,388 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,000 | 4,000 | 4,000 | N/A | N/A |
| Deferred Revenues | 12,651 | 10,503 | 12,760 | 8,294 | 9,417 |
| Other Non-Current Liabilities | 745 | 720 | 684 | 540 | 320 |
| TOTAL | $9,132 | $9,857 | $10,571 | $540 | $320 |
| Total Liabilities | $33,072 | $26,646 | $31,870 | $17,886 | $18,708 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,937 | 7,502 | 7,484 | 7,481 | 7,475 |
| Common Shares | 52 | 52 | 52 | 52 | 52 |
| Retained earnings | -184,509 | -166,890 | -149,745 | -135,883 | -119,074 |
| Other shareholders' equity | -5,988 | -8,507 | -11,106 | -13,811 | -16,648 |
| TOTAL | $140,322 | $155,321 | $169,902 | $181,003 | $195,127 |
| Total Liabilities And Equity | $173,394 | $181,967 | $201,772 | $198,889 | $213,835 |